News
Article
On February 19, the FDA approved acalabrutinib tablets and capsules in combination with venetoclax for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
For more information, read the FDA announcement and the AstraZeneca press release.
Posted on 2/20/2026